Advancing Research
by supporting Grant Programs and Fellowships
Driving Innovation
by championing the TAME Trial and Geroscience
Furthering the Field
by leading Coordinating Centers and Professional Services
Thanks to the science AFAR supports, we are making constant progress toward a simple and compelling vision: the ability for all of us to live healthier each and every day of our lives.
The AFAR-managed TAME (Targeting Aging with Metformin) Trial will establish a proof-of-concept that aging processes can be treated, just as we treat diseases.
The TAME Trial ultimately seeks the FDA to make aging an "indication" for treatment.
If aging is made an indication, the TAME Trial will mark a paradigm shift: from treating each age-related medical condition separately, to treating these conditions together, by targeting aging per se.
New book by AFAR Scientific Director Nir Barzilai, MD
AFAR serves as the Coordinating Center for three initiatives funded by the National Institute on Aging.
AFAR-supported investigators are advancing research that will move from the labs into our lives. Join us as we embark on the next frontier of health aging.
AFAR is grateful for collaboration and support of our program partners, including:
AFAR is proud to consistently receive the highest ratings from respected charity evaluators